Dr. Michael Wang is Chief Strategy Officer with the National Foundation for Cancer Research (NFCR). There he is actively involved in developing strategic alliances and critical collaborations with international organizations in both academic and industrial communities. Dr. Wang too works closely with university technology transfer offices to facilitate the protection and commercialization of NFCR-sponsored intellectual property. He has extensive experience in scientific program management, strong capability for technical and financial due diligence, and broad knowledge about early-stage technology evaluation and development. Dr.Wang has previously served as Chief Science Officer overseeing all aspects of NFCR’s cancer research programs and research initiatives. He remains actively involved in identifying collaborative opportunities so that cancer researchers from Asia can work closely with scientists from the U.S. and Europe.
Dr. Wang received his medical degree from the Second Military Medical College in Shanghai, China, his Ph.D. in molecular biology from Kyoto University, Japan, and his M.B.A. from Penn State University. Before joining NFCR in 2002, Dr. Wang had worked at the University of Pennsylvania as a Research Fellow and at a leading technology transfer company, British Technology Group, as a Senior Business Development Manager for both its Oncology group and Genomics and Proteomics group.